Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Complex genome engineering with the Pin-point base editing system
Complex genome engineering with the Pin-point base editing system
Application Note

Complex genome engineering with the Pin-point base editing system

When performing gene editing using CRISPR-Cas systems, the double strand DNA breaks introduced can be cytotoxic, particularly in sensitive cell types. These cytotoxic effects are amplified when multiple target sites are edited at the same time because the cell must repair multiple breaks to the genome.

Read this application note to find out how the Pin-point™ base editing platform can be applied to complex gene editing, even in sensitive cell types.

Pin-point™ base editing reagents are available for research use only and are not for diagnostic use or direct administration into humans or animals. The Pin-point™ base editing platform technology is available for clinical or diagnostic study and commercialization under a commercial license from Revvity.

For research use only. Not for use in diagnostic procedures.

Download Resource

Complex genome engineering with the Pin-point base editing system

Download Application Note
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.